Wulf O. Boecher
- Hepatology top 1%
- Epidemiology top 5%
- Infectious Diseases
- Rheumatology
- Surgery
- Co-authors
- Peter BuggischStefan ZeuzemThomas BergMichael P. MannsMarcus SchuchmannHeiner WedemeyerAnsgar W. LohseJohannes Wiegand
- Topics
- Hepatitis C virus research (10 papers)Hepatitis B Virus Studies (6 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Journals
- GastroenterologyPLoS ONEHepatology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Wulf O. Boecher
12 papers receiving 577 citations
Peers
Comparison fields: 5 of 44
- Hepatology 553
- Epidemiology 499
- Infectious Diseases 103
- Rheumatology 63
- Surgery 54
Countries citing papers authored by Wulf O. Boecher
This map shows the geographic impact of Wulf O. Boecher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wulf O. Boecher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wulf O. Boecher more than expected).
Fields of papers citing papers by Wulf O. Boecher
This network shows the impact of papers produced by Wulf O. Boecher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wulf O. Boecher. The network helps show where Wulf O. Boecher may publish in the future.
Co-authorship network of co-authors of Wulf O. Boecher
This figure shows the co-authorship network connecting the top 25 collaborators of Wulf O. Boecher. A scholar is included among the top collaborators of Wulf O. Boecher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wulf O. Boecher. Wulf O. Boecher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | HCVerso2: a phase III study of faldaprevir plus deleobuvir and ribavirin for chronic HCV genotype 1b infection in treatment naïve patients including those ineligible for pegylated interferon | 1 |
| 2 | 16 | |
| 3 | 101 | |
| 4 | 34 | |
| 5 | 89 | |
| 6 | Virological response and safety of BI 201335 protease inhibitor, peginterferon alfa 2a and ribavirin treatment of HCV genotype-1 patients with compensated liver cirrhosis and non-response to previous peginterferon/ribavirin | 1 |
| 7 | 131 | |
| 8 | 56 | |
| 9 | 2 | |
| 10 | 149 | |
| 11 | 11 | |
| 12 | 2 |
About Wulf O. Boecher
Wulf O. Boecher is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 12 papers that have together received 593 indexed citations. Recurring topics across this work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (553 citations), Epidemiology (499 citations) and Infectious Diseases (103 citations). Wulf O. Boecher has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Peter Buggisch, Stefan Zeuzem, Thomas Berg, Michael P. Manns, Marcus Schuchmann, Heiner Wedemeyer, Ansgar W. Lohse, Johannes Wiegand, B. Kallinowski and Markus Cornberg. Their work appears in journals such as Gastroenterology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.